GCM
KLRS

Graham Capital Management’s Kalaris Therapeutics, Inc. Common Stock KLRS Stock Holding History

Graham Capital Management’s Portfolio KLRS Stock Details KLRS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-3,576
Closed -$55.9K – 1328
2023
Q4 		$55.9K Buy
3,576
+3,056
+588% +$47.8K ﹤0.01% 912
2023
Q3 		$25.7K Buy
+520
New +$25.7K ﹤0.01% 963
2022
Q4 		– Sell
-562
Closed -$102K – 1397
2022
Q3 		$102K Buy
+562
New +$102K ﹤0.01% 1016